Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at HUF 70.92T, ahead of Johnson & Johnson (HUF 67.88T) and Merck & Co (HUF 46.63T). Figures as of 20 Nov 2026, 19:16 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerHUF 70.92T
- Median
- HUF 508.6B
- Combined market value
- HUF 1280.34T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | HUF 70.92T | HUF 53.57T | HUF 9,398.84 | 0.16% up | 10% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | HUF 67.88T | HUF 223.03T | HUF 92,647.69 | 1.79% up | 31% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 46.63T | HUF 113.16T | HUF 45,903.91 | 1.44% up | 36% up | ||
| 4 | AbbVieABBV · Health Care | HUF 45.64T | HUF 173.8T | HUF 98,325.84 | 1.78% up | 20% up | ||
| 5 | Eli LillyLLY · Health Care | HUF 38.32T | HUF 410.24T | HUF 460,562.09 | 0.04% up | 28% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | HUF 30.68T | HUF 41.14T | HUF 20,126.51 | 1.25% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | HUF 29.55T | HUF 61.39T | HUF 35,445.41 | 0.15% up | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | HUF 13.82T | HUF 32.44T | HUF 313,601.79 | 0.22% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | HUF 12.67T | HUF 7.67T | HUF 6,686.69 | 1.28% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | HUF 8.74T | HUF 44.89T | HUF 177,050.13 | 0.20% down | 22% up | ||
| 11 | Royalty PharmaRPRX · Health Care | HUF 6.69T | HUF 13.42T | HUF 23,336.12 | 1.14% up | 74% up | ||
| 12 | ZoetisZTS · Health Care | HUF 5.27T | HUF 11.08T | HUF 27,257.84 | 0.98% down | 34% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | HUF 4.55T | HUF 4.38T | HUF 8,768.51 | 2.11% down | 18% up | ||
| 14 | United TherapeuticsUTHR · Health Care | HUF 2.68T | HUF 8.06T | HUF 189,159.19 | 0.70% down | 18% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | HUF 2.59T | HUF 4T | HUF 20,625.67 | 1.44% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.69T | HUF 6.72T | HUF 50,168.05 | 0.39% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.25T | HUF 2.53T | HUF 7,260.81 | 0.37% down | 79% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | HUF 1.2T | HUF 1.54T | HUF 9,228.48 | 0.50% down | 64% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | HUF 987.7B | HUF 1.63T | HUF 19,475.73 | 2.00% down | 26% down | ||
| 20 | InsmedINSM · Health Care | HUF 771.6B | HUF 10.73T | HUF 48,905.68 | 0.64% down | 27% down | ||
| 21 | Legend BiotechLEGN · Health Care | HUF 590.7B | HUF 1.01T | HUF 5,196.03 | 5.28% down | 43% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | HUF 531.7B | HUF 1.96T | HUF 97,845.42 | 0.08% up | 44% up | ||
| 23 | CytokineticsCYTK · Health Care | HUF 485.4B | HUF 2.43T | HUF 17,468.87 | 0.37% down | 21% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 472B | HUF 2.03T | HUF 14,361.47 | 3.44% down | 8% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 429.2B | HUF 3.06T | HUF 131,835.95 | 2.47% down | 28% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | HUF 362.3B | HUF 3.32T | HUF 21,939.15 | 0.76% down | 103% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | HUF 319.6B | HUF 2.9T | HUF 103,603.64 | 2.20% down | 83% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | HUF 319.5B | HUF 1.61T | HUF 9,248.93 | 2.14% down | 25% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | HUF 318.9B | HUF 5.08T | HUF 26,082.35 | 2.08% down | 15% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | HUF 287.2B | HUF 2.16T | HUF 33,097.83 | 1.71% up | 35% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | HUF 285.1B | HUF 2.38T | HUF 21,707.46 | 1.95% down | 16% down | ||
| 32 | Belite BioBLTE · Health Care | HUF 266B | HUF 1.86T | HUF 45,716.51 | 11.15% down | 25% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | HUF 265B | HUF 3.04T | HUF 32,022.85 | 3.73% down | 302% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | HUF 255.9B | HUF 2.74T | HUF 3,424.27 | 4.92% down | 35% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | HUF 235B | HUF 2.33T | HUF 44,345.10 | 4.08% down | 9% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | HUF 227.7B | HUF 2.72T | HUF 41,747.09 | 1.21% down | 45% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | HUF 206.2B | HUF 1.57T | HUF 16,351.30 | 0.64% down | 39% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | HUF 188.3B | HUF 1.5T | HUF 13,705.58 | 2.30% down | 82% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | HUF 180.9B | HUF 1.61T | HUF 28,647.99 | 0.88% down | 105% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | HUF 166.5B | HUF 2.17T | HUF 32,038.18 | 3.63% down | 233% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 163.6B | HUF 2.7T | HUF 38,975.30 | 2.06% down | 15% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | HUF 150B | HUF 1.35T | HUF 9,829.86 | 2.14% down | 176% up | ||
| 43 | ErascaERAS · Health Care | HUF 135B | HUF 1.67T | HUF 4,763.31 | 1.69% down | 387% up | ||
| 44 | VeradermicsMANE · Health Care | HUF 52B | HUF 1.73T | HUF 41,062.23 | 3.12% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 340.7 HUF).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (HUF 70.92T), Johnson & Johnson (HUF 67.88T) and Merck & Co (HUF 46.63T) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 19:16 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of HUF 1280.34T as of 20 Nov 2026, 19:16 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.